Ionosol Mb And Dextrose 5% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Ionosol Mb And Dextrose 5% In Plastic Container


Drug - Ionosol Mb And Dextrose 5% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dextrose; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Sodium Lactate; Sodium Phosphate, Monobasic, Anhydrous
Multiple ingredients are in alphabetical order.

Strength - 5GM/100ML;30MG/100ML;141MG/100ML;15MG/100ML;260MG/100ML;25MG/100ML
The potency of the active ingredient(s), Dextrose; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Sodium Lactate; Sodium Phosphate, Monobasic, Anhydrous. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Ionosol Mb And Dextrose 5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019513
The FDA assigned number to Ionosol Mb And Dextrose 5% In Plastic Container. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ionosol Mb And Dextrose 5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 8, 1986
The date Ionosol Mb And Dextrose 5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ionosol Mb And Dextrose 5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ionosol Mb And Dextrose 5% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Ionosol Mb And Dextrose 5% In Plastic Container.

Ionosol Mb And Dextrose 5% In Plastic Container


Plasma-lyte 56 And Dextrose 5% In Plastic Container 5gm/100ml;32mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Normosol-m And Dextrose 5% In Plastic Container 5gm/100ml;21mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Isolyte P In Dextrose 5% In Plastic Container 5gm/100ml;31mg/100ml;130mg/100ml;26mg/100ml;320mg/100ml Injectable; Injection
Isolyte P W/ Dextrose 5% In Plastic Container 5gm/100ml;31mg/100ml;130mg/100ml;26mg/100ml;320mg/100ml Injectable; Injection
Ionosol B And Dextrose 5% In Plastic Container 5gm/100ml;53mg/100ml;100mg/100ml;100mg/100ml;180mg/100ml;280mg/100ml;16mg/100ml Injectable; Injection
Dextrose 5% And Electrolyte No.48 In Plastic Container 5gm/100ml;31mg/100ml;141mg/100ml;20mg/100ml;12mg/100ml;260mg/100ml Injectable; Injection
Ionosol Mb And Dextrose 5% In Plastic Container 5gm/100ml;30mg/100ml;141mg/100ml;15mg/100ml;260mg/100ml;25mg/100ml Injectable; Injection
Dextrose 70% In Plastic Container 70gm/100ml Injectable; Injection
Dextrose 70% In Plastic Container 70gm/100ml Injectable; Injection
Dextrose 70% In Plastic Container 70gm/100ml Injectable; Injection

NewDrugInformation